The level of RCAS1 expression is inversely correlated with the number of vimentin-positive stromal cells in epithelial ovarian cancer

International Journal of Gynecological Cancer

Volumn 19, Issue 5, 2009, Pages 838-843

  Sonoda, Kenzo ^a   Miyamoto, Shingo ^b   Kobayashi, Hiroaki ^a   Ogawa, Shinji ^a   Okugawa, Kaoru ^a   Taniguchi, Shuichi ^a   Wake, Norio ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Connective tissue remodeling; Immunohistochemistry; Ovarian cancer; RCAS1; Vimentin

Indexed keywords

MEMBRANE PROTEIN; PLATINUM; RECEPTOR BINDING CANCER ANTIGEN 1; TAXANE DERIVATIVE; UNCLASSIFIED DRUG; VIMENTIN; EBAG9 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PATIENT; CANCER SURGERY; CANCER TISSUE; CELL STIMULATION; CELL STRAIN L 929; CONNECTIVE TISSUE; CYTOLOGY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROVASCULATURE; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STROMA CELL; TISSUE REGENERATION; TUMOR VASCULARIZATION; WESTERN BLOTTING; CANCER STAGING; ENZYME IMMUNOASSAY; FIBROBLAST; METABOLISM; MIDDLE AGED; MORTALITY; NEOPLASM; OVARY TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; FEMALE; FIBROBLASTS; HUMANS; IMMUNOENZYME TECHNIQUES; MICROVESSELS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; STROMAL CELLS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 69449099712     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a5ff6a     Document Type: Article

References (19)

1. American Society Cancer. Cancer Facts & FiguresV2008. American Cancer Society Inc; 2008. http://www.cancer.org. Accessed February 1, 2009.
2. Marugame T, Matsuda T, Kamo K, et al. Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries. Jpn J Clin Oncol. 2007;37:884-891. (Pubitemid 350259009)
3. Karlan BY, Baldwin RL, Cirisano FD, et al. Secreted ovarian stromal substance inhibits ovarian epithelial cell proliferation. Gynecol Oncol. 1995;59:67-74.
4. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med. 1999;5:938-942.
5. Sonoda K, Miyamoto S, Nakashima M, et al. The biological role of unique molecule RCAS1: a bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis. Front Biosci. 2008; 13:1106-1116.
6. Sonoda K, Miyamoto S, Hirakawa T, et al. Invasive potency related to RCAS1 expression in uterine cervical cancer. Gynecol Oncol. 2005;99:189-198.
7. Sonoda K, Miyamoto S, Yamazaki A, et al. Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer. Cancer. 2007;110:1979-1990.
8. Razvi K, Sonoda K, Lee YS, et al. A preliminary study of the immunohistochemical detection of a novel tumour marker, 22-1-11 antigen, in gynaecological cancer specimens. Ann Acad Med Singapore. 1999;28:392-394.
9. Akahira J, Aoki M, Suzuki T, et al. Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer. Br J Cancer. 2004;90:2197-2202. (Pubitemid 38869730)
10. Carey I, Zehner ZE. Regulation of chicken vimentin gene expression by serum, phorbol ester, and growth factors: identification of a novel fibroblast growth factor-inducible elements. Cell Growth Diff. 1995;6:899-908.
11. Kokkinos MI, Wafai R, Wong MK, et al. Vimentin and epithelialmesenchymal transition in human breast cancer-observations in vitro and in vivo. Cells Tissues Organs. 2007;185:191-203.
12. Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol. 2006;1:119-150.
13. Byun Y, Chen F, Chang R, et al. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ. 2001;8:443-450.
14. Tsuchiya F, Ikeda K, Tsutsumi O, et al. Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen. Biochem Biophys Res Commun. 2001;284:2-10.
15. Nilsson EE, Skinner MK. Role of transforming growth factor beta in ovarian surface epithelium biology and ovarian cancer. Reprod Biomed Online. 2002;5:254-258.
16. Eckes B, Dogic D, Colucci-Guyon E, et al. Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci. 1998;111:1897-1907.
17. Nieminen M, Henttinen T, Merinen M, et al. Vimentin function in lymphocyte adhesion and transcellular migration. Nat Cell Biol. 2006;8:156-162.
18. Davis GE, Senger DR. Endothelial extracellular matrix. Biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res. 2005;97:1093-1107.
19. Ramakrishnan S, Subramanian IV, Yokoyama Y, et al. Angiogenesis in normal and neoplastic ovaries. Angiogenesis. 2005;8:169-182.